rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2002-12-20
|
pubmed:abstractText |
To assess prevalence of cardiac valvular lesions in patients with primary (P) antiphospholipid syndrome (APLS) and systemic lupus erythematosus (SLE) with and without secondary APLS.
|
pubmed:language |
rus
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0022-9040
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
38-43
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:12494093-Adolescent,
pubmed-meshheading:12494093-Adult,
pubmed-meshheading:12494093-Antiphospholipid Syndrome,
pubmed-meshheading:12494093-Female,
pubmed-meshheading:12494093-Heart Valve Diseases,
pubmed-meshheading:12494093-Heart Valves,
pubmed-meshheading:12494093-Humans,
pubmed-meshheading:12494093-Lupus Erythematosus, Systemic,
pubmed-meshheading:12494093-Male,
pubmed-meshheading:12494093-Middle Aged,
pubmed-meshheading:12494093-Phospholipids
|
pubmed:year |
2002
|
pubmed:articleTitle |
[Cardiological aspects of the antiphospholipid syndrome. Part I. Valvular lesions in the primary and secondary antiphospholipid syndrome and systemic lupus erythematosus].
|
pubmed:publicationType |
Journal Article,
English Abstract
|